Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
2006 1
2007 1
2008 1
2009 1
2012 2
2013 1
2014 2
2015 3
2016 3
2017 5
2018 7
2019 6
2020 12
2021 6
2022 22
2023 17
2024 26
2025 28
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines.
Yamout B, Al-Jumah M, Sahraian MA, Almalik Y, Khaburi JA, Shalaby N, Aljarallah S, Bohlega S, Dahdaleh M, Almahdawi A, Khoury SJ, Koussa S, Slassi E, Daoudi S, Aref H, Mrabet S, Zeineddine M, Zakaria M, Inshasi J, Gouider R, Alroughani R. Yamout B, et al. Among authors: mrabet s. Mult Scler Relat Disord. 2024 Mar;83:105435. doi: 10.1016/j.msard.2024.105435. Epub 2024 Jan 7. Mult Scler Relat Disord. 2024. PMID: 38245998 Review.
Cirrhotic cardiomyopathy.
Elleuch N, Mrabet S, Ben Slama A, Jaziri H, Hammami A, Brahim A, Ajmi S, Ksiaa M, Jmaa A. Elleuch N, et al. Among authors: mrabet s. Tunis Med. 2020 Mar;98(3):206-210. Tunis Med. 2020. PMID: 32395813 Free article. Review.
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.
Müller J, Sharmin S, Lorscheider J, Ozakbas S, Karabudak R, Horakova D, Weinstock-Guttman B, Shaygannejad V, Etemadifar M, Alroughani R, Patti F, Eichau S, Prat A, Lugaresi A, Tomassini V, Kermode AG, Amato MP, Turkoglu R, Altintas A, Buzzard K, Soysal A, van der Walt A, Butzkueven H, Blanco Y, Gerlach O, Khoury SJ, Barnett M, John N, Lechner-Scott J, Foschi M, Surcinelli A, van Pesch V, Prevost J, Sa MJ, Maimone D, D'hooghe M, Hughes S, Hodgkinson S, McGuigan C, Cartechini E, Taylor B, Spitaleri D, Slee M, McCombe P, Yamout B, Benkert P, Kuhle J, Kappos L, Roos I, Kalincik T; MSBase Study Group; Havrdova EK, Girard M, Duquette P, Fabis-Pedrini M, Carroll WM, Skibina O, Gouider R, Mrabet S, Ramo-Tello C, Solaro C, Habek M, Van Wijmeersch B, Ampapa R, Macdonell R, Oreja-Guevara C, de Gans K, Laureys G, Oh J, Garber J, Gray O, Agüera-Morales E, Sanchez-Menoyo JL, Castillo-Triviño T, Grigoriadis N, Petersen T, Hardy TA, Vucic S, Reddel S, Ramanathan S, Al-Asmi A, Simu M, Baghbanian SM, Poehlau D, Al-Harbi T, Rojas JI, Deri N, Lalive P, Cambron M, Csepany T, Shuey N, Willekens B, Shaw C, Decoo D, Massey J, Yaldizli Ö, Derfuss T, Granziera C. Müller J, et al. Among authors: mrabet s. JAMA Neurol. 2025 Jun 1;82(6):614-625. doi: 10.1001/jamaneurol.2025.0495. JAMA Neurol. 2025. PMID: 40227706 Free PMC article.
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies.
Yeh WZ, Van Der Walt A, Skibina OG, Kalincik T, Alroughani R, Kermode AG, Fabis-Pedrini MJ, Carroll WM, Lechner-Scott J, Boz C, Ozakbas S, Buzzard K, Habek M, John NA, Prat A, Girard M, Duquette P, Baghbanian SM, Hodgkinson S, Van Pesch V, Laureys G, Willekens B, Prevost J, Foschi M, De Gans K, Horakova D, Havrdova EK, Karabudak R, Patti F, Mccombe PA, Maimone D, Altintas A, Ampapa R, Spitaleri D, Gerlach OHH, Sa MJ, Hughes S, Gouider R, Mrabet S, Macdonell RA, Turkoglu R, Cartechini E, Al-Asmi A, Soysal A, Oh J, Muros-Le Rouzic E, Guye S, Pasquarelli N, Butzkueven H, Jokubaitis VG; MSBase Study Group. Yeh WZ, et al. Among authors: mrabet s. Neurol Neuroimmunol Neuroinflamm. 2024 Nov;11(6):e200328. doi: 10.1212/NXI.0000000000200328. Epub 2024 Oct 23. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 39442037 Free PMC article.
Stroke in Djibouti.
Nour MA, Mrabet S, Maidal MA, Gharbi A, Abida Y, Souissi A, Gargouri A, Kacem I, Nasri A, Gouider R. Nour MA, et al. Among authors: mrabet s. Afr J Emerg Med. 2022 Jun;12(2):141-147. doi: 10.1016/j.afjem.2022.03.002. Epub 2022 Apr 12. Afr J Emerg Med. 2022. PMID: 35462861 Free PMC article.
Pregnancy-Related Disease Outcomes in Women With Moderate to Severe Multiple Sclerosis Disability.
Shipley J, Beadnall HN, Sanfilippo PG, Yeh WZ, Horakova D, Havrdova EK, Hradilek P, Kalincik T, Roos I, Prat A, Girard M, Rous Z, Pavelek Z, Gerlach OHH, Lechner-Scott J, Alroughani R, Ozakbas S, Peterka M, Buzzard K, Skibina OG, Maimone D, Foschi M, Surcinelli A, Karabudak R, Spitaleri DLA, Lugaresi A, Tomassini V, Gouider R, Mrabet S, Ferrando BR, Hodgkinson S, Štourac P, Guimarães J, John NA, Macdonell RAL, Meca-Lallana JE, Butzkueven H, van der Walt A, Jokubaitis VG; MSBase Investigator Group. Shipley J, et al. Among authors: mrabet s. JAMA Netw Open. 2025 Sep 2;8(9):e2531581. doi: 10.1001/jamanetworkopen.2025.31581. JAMA Netw Open. 2025. PMID: 40952740 Free PMC article.
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Kalincik T, Sharmin S, Roos I, Freedman MS, Atkins H, Burman J, Massey J, Sutton I, Withers B, Macdonell R, Grigg A, Torkildsen Ø, Bo L, Lehmann AK, Havrdova EK, Krasulova E, Trnený M, Kozak T, van der Walt A, Butzkueven H, McCombe P, Skibina O, Lechner-Scott J, Willekens B, Cartechini E, Ozakbas S, Alroughani R, Kuhle J, Patti F, Duquette P, Lugaresi A, Khoury SJ, Slee M, Turkoglu R, Hodgkinson S, John N, Maimone D, Sa MJ, van Pesch V, Gerlach O, Laureys G, Van Hijfte L, Karabudak R, Spitaleri D, Csepany T, Gouider R, Castillo-Triviño T, Taylor B, Sharrack B, Snowden JA; MSBase Study Group Collaborators; MSBase Study Group Authors; Mrabet S, Garber J, Sanchez-Menoyo JL, Aguera-Morales E, Blanco Y, Al-Asmi A, Weinstock-Guttman B, Fragoso Y, de Gans K, Kermode A; MSBase Study Group. Kalincik T, et al. Among authors: mrabet s. JAMA Neurol. 2023 Jul 1;80(7):702-713. doi: 10.1001/jamaneurol.2023.1184. JAMA Neurol. 2023. PMID: 37437240 Free PMC article.
Psychiatric disturbances in idiopathic epilepsy.
Mrabet S, Belguith S, Kacem I, Zgueb Y, Jenhani R, Ouali U, Nasri A, Abdelkefi I, Ben Djebara M, Jomli R, Gargouri Berrechid A, Gouider R. Mrabet S, et al. Tunis Med. 2023 Nov 5;101(11):839-844. Tunis Med. 2023. PMID: 38468585 Free PMC article. English.
What to Do with the New Antibiotics?
Chaïbi K, Jaureguy F, Do Rego H, Ruiz P, Mory C, El Helali N, Mrabet S, Mizrahi A, Zahar JR, Pilmis B. Chaïbi K, et al. Among authors: mrabet s. Antibiotics (Basel). 2023 Mar 27;12(4):654. doi: 10.3390/antibiotics12040654. Antibiotics (Basel). 2023. PMID: 37107016 Free PMC article. Review.
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.
Daruwalla C, Kremler C, Patti F, Ozakbas S, Boz C, Lechner-Scott J, Surcinelli A, Foschi M, Khoury SJ, Butzkueven H, van der Walt A, Rous Z, Habek M, Meca-Lallana JE, Lopez GV, Alroughani R, Blanco Y, Laureys G, Skibina O, Buzzard K, Gray O, McCombe P, Maimone D, Duquette P, Girard M, Prat A, Sanchez-Menoyo JL, van Pesch V, Soysal A, Amato MP, Grand'Maison F, Wilton J, Van Wijmeersch B, Gerlach O, Lugaresi A, Tomassini V, De Luca G, Taylor B, Foong YC, John N, Cárdenas-Robledo S, Hodgkinson S, Macdonell R, Willekens B, Garber J, D'Amico E, Terzi M, Houskova J, Lapointe E, Al-Asmi A, Barnett M, Stetkarova I, Gouider R, Mrabet S, Csepany T, McGuigan C, Gross-Paju K, Kuhle J, Castillo-Triviño T, Kerrigan S, Tolkovsky AM, Wardle M, Cunniffe NG, Roos I, Madley-Dowd P, Coles A, Kalincik T, Sterne JAC, William Brown JL; MSBase study group. Daruwalla C, et al. Among authors: mrabet s. Brain. 2026 Jul 24:awag252. doi: 10.1093/brain/awag252. Online ahead of print. Brain. 2026. PMID: 42496160 Free article.
157 results